Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo
about
Bile Acid diarrhea: prevalence, pathogenesis, and therapyChemoproteomic Profiling of Bile Acid Interacting ProteinsAdvances in understanding of bile acid diarrhea.The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.The role of bile acids in functional GI disorders.Bile acid malabsorption in inflammatory bowel disease.Chenodeoxycholic acid requires activation of EGFR, EPAC, and Ca2+ to stimulate CFTR-dependent Cl- secretion in human colonic T84 cells.Lithocholic acid attenuates cAMP-dependent Cl- secretion in human colonic epithelial T84 cells.Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells.The expanding role of the bile acid receptor farnesoid X in the intestine and its potential clinical implications.The Zn2+-sensing receptor, ZnR/GPR39, upregulates colonocytic Cl- absorption, via basolateral KCC1, and reduces fluid loss.The Farnesoid X Receptor: Good for BAD.Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells.Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.The Bile Acids, Deoxycholic Acid and Ursodeoxycholic Acid, Regulate Colonic Epithelial Wound Healing.A rapid administration of GW4064 inhibits the NLRP3 inflammasome activation independent of farnesoid X receptor agonism.
P2860
Q28086845-1DA8A6DC-1DB3-45F8-AAF1-14652CEB8018Q33731122-EF3AE201-E810-41F3-BD97-CFA1C3351293Q34412381-F2E08C80-088E-4639-8190-8C4B7B85C1BFQ34444158-B37D0DAB-3740-48EC-BF09-59E1B107A679Q38217671-D845D63B-79B5-4318-A351-3CE37E94435DQ38253467-E5EE8E15-64A7-4C8E-8121-192D79960FC5Q38734395-F3F229FD-52AE-4D60-9CC4-3C66E64544BCQ38778372-A2A175F3-D767-4719-B620-F518675EA945Q38866694-9D47645B-70C1-45E8-A1C7-80C056E795C5Q38967650-9214AC1E-2131-41E4-BE97-241402813D0CQ39017825-80D73FF7-350D-4D5B-88BF-D89FB82C130DQ39125255-6EDBA5C4-7D9D-454D-BE33-19EF6B80BAE7Q42461659-8D7EA9F0-A8B8-4E15-B497-12E9B03F56F6Q42494201-F8EF68DD-9305-48DC-BA88-2CDC857E5480Q47651605-9935B0A6-BB30-41C0-9812-194008A7217AQ47978129-46E6C85E-917E-441F-ADAA-AD992BEC9A87
P2860
Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@ast
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@en
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@nl
type
label
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@ast
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@en
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@nl
prefLabel
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@ast
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@en
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@nl
P2093
P2860
P1433
P1476
Farnesoid X receptor agonists ...... experimental diarrhoea in vivo
@en
P2093
Gabriella Aviello
Joseph B Ward
Magdalena S Mroz
Mark Donowitz
Niamh Keating
Padraic G Fallon
Rafiquel Sarker
Silvie Amu
Stephen J Keely
P2860
P304
P356
10.1136/GUTJNL-2013-305088
P407
P577
2014-05-01T00:00:00Z